Risk Factors and Preventive Measures for Lung Cancer in the European Union

Background: Lung cancer is worldwide one of the most common types of cancer with still very high mortality rates. The aim of this study was to identify and demonstrate correlations between lung cancer mortality rates and potential influencing factors in EU countries. Methods: This retrospective stud...

Full description

Saved in:
Bibliographic Details
Main Authors: Katharina Kehrle (Author), Michael Hetjens (Author), Svetlana Hetjens (Author)
Format: Book
Published: MDPI AG, 2024-08-01T00:00:00Z.
Subjects:
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

MARC

LEADER 00000 am a22000003u 4500
001 doaj_d974fb8ddb6a4f8eaaf7fc46d27e8360
042 |a dc 
100 1 0 |a Katharina Kehrle  |e author 
700 1 0 |a Michael Hetjens  |e author 
700 1 0 |a Svetlana Hetjens  |e author 
245 0 0 |a Risk Factors and Preventive Measures for Lung Cancer in the European Union 
260 |b MDPI AG,   |c 2024-08-01T00:00:00Z. 
500 |a 10.3390/epidemiologia5030037 
500 |a 2673-3986 
520 |a Background: Lung cancer is worldwide one of the most common types of cancer with still very high mortality rates. The aim of this study was to identify and demonstrate correlations between lung cancer mortality rates and potential influencing factors in EU countries. Methods: This retrospective study investigated the connections between the mortality rates in the EU countries (n = 28) and potential influencing factors. The significant factors from the correlation analysis were identified using a stepwise multiple regression analysis. Results: The most important factors for both genders are the incidence of lung cancer, the price of tobacco, and the number of doctors per 100,000 inhabitants. Conclusion: Lung cancer is a significant global health challenge. The study identified potential strategies for reducing the mortality rate from lung cancer. These strategies include an increase in the number of physicians, enhanced accessibility to cutting-edge antineoplastic medications, and state-funded coverage of the associated costs. It would be beneficial for politicians to consider implementing LDCT screening for the early detection of the disease. The implementation of uniform healthcare system optimization across the EU, combined with improvements in socio-economic conditions, has the potential to mitigate the risk of developing lung cancer. 
546 |a EN 
690 |a prevention 
690 |a lung cancer 
690 |a mortality 
690 |a Internal medicine 
690 |a RC31-1245 
655 7 |a article  |2 local 
786 0 |n Epidemiologia, Vol 5, Iss 3, Pp 539-546 (2024) 
787 0 |n https://www.mdpi.com/2673-3986/5/3/37 
787 0 |n https://doaj.org/toc/2673-3986 
856 4 1 |u https://doaj.org/article/d974fb8ddb6a4f8eaaf7fc46d27e8360  |z Connect to this object online.